Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | DNM2 | P50570 | 7/20 | 0.42 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 3/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1152325 | 1.00 | KMT2A (0.45) | KMT2ADNM2KCNH3PPARAFAAH | |
| SCHEMBL1152331 | 1.00 | KMT2A (0.45) | KMT2ADNM2KCNH3PPARAFAAH | |
| Potassium SCHEMBL1151581 | 0.98 | KMT2A (0.44) | KMT2ADNM2KCNH3PPARAFAAH | |
| SCHEMBL7645905 | 0.98 | KMT2A (0.44) | KMT2ADNM2KCNH3PPARAFAAH | |
| SCHEMBL7645913 | 0.98 | KMT2A (0.44) | KMT2ADNM2KCNH3PPARAFAAH | |
| SCHEMBL1151575 | 0.98 | KMT2A (0.44) | KMT2ADNM2KCNH3PPARAFAAH | |
| Potassium SCHEMBL29627245 | 0.98 | KMT2A (0.44) | KMT2ADNM2KCNH3PPARAFAAH | |
| SCHEMBL2570949 | 0.90 | KMT2A (0.53) | KMT2ADNM2KCNH3 | |
| SCHEMBL21295420 | 0.90 | KMT2A (0.53) | KMT2ADNM2KCNH3 | |
| SCHEMBL2804052 | 0.90 | KMT2A (0.53) | KMT2ADNM2KCNH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1394153-B1 | THIOL COMPOUND DERIVATIVES, HARDENING COMPOSITIONS CONTAINING THESE DERIVATIVES AND MOLDED ARTICLES THEREOF | UNIMATEC CO LTD (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-7812157-B2 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20080227977-A1 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. | 2008-09-18 | — | — | US | disclosed |
| US-7384995-B2 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. (JP) | 2008-06-10 | — | — | US | disclosed |
| US-20070155868-A1 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. | 2007-07-05 | — | — | US | disclosed |
| US-7199169-B2 | Thiol compound derivative, hardening compositions containing these derivatives and molded articles thereof | UNIMATEC CO., LTD. (JP) | 2007-04-03 | — | — | US | disclosed |
| US-20040162368-A1 | Thiol compound derivative, hardening compositions containing these derivatives and molded articles thereof | UNIMATEC CO., LTD. (JP) | 2004-08-19 | — | — | US | disclosed |
| EP-1394153-A1 | THIOL COMPOUND DERIVATIVES, HARDENING COMPOSITIONS CONTAINING THESE DERIVATIVES AND MOLDED ARTICLES THEREOF | Unimatec Co., Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227977-A1 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | TST, CTH, NACA | KMT2A 1089/4885DNM2 4825/4885KCNH3 2780/4885 |
| US-20040162368-A1 | Thiol compound derivative, hardening compositions containing these derivatives and molded articles thereof | TST, NACA, CTH | KMT2A 507/4885DNM2 4125/4885KCNH3 2759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.